Garry Nolan

Garry Nolan is a distinguished immunologist and Stanford University School of Medicine professor with more than 300 published research articles, 40 U.S. patents, and a role in founding eight biotechnology companies, credentials that made him an unusually credible scientific figure when he began UAP-related research after being approached in 2013 by intelligence-community-connected contacts investigating anomalous health effects reported among military personnel and pilots. Over roughly a decade, Nolan has led forensic materials analysis on samples reportedly connected to UAP incidents and physiological studies of individuals reporting close-proximity encounters, applying the same rigorous laboratory methodology used in his cancer and immunology research, with a stated goal of building reproducible, peer-reviewable analytical pipelines rather than relying on anecdotal testimony. He has stated publicly that he personally believes non-human intelligence is plausibly present based on his research, while emphasizing as a working scientist that the evidentiary threshold for public scientific proof has not yet been met, a carefully calibrated position distinguishing him from more categorical advocates. Nolan serves as executive director of the board of the Sol Foundation, a nonprofit that convened academic UAP policy and research symposia at Stanford in 2023 and 2024, working to establish standardized scientific protocols for the field, positioning him as one of the most institutionally credentialed scientists actively engaged in UAP materials research.